SightfileU.S. market data from official filings

GENELUX CORPORATION (GNLX)

Name: GENELUX CORPORATION (GNLX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001231457 · EDGAR filings · Updated 2026-07-02

GENELUX CORPORATION (GNLX) has reported institutional ownership of 20.7%, with 70 institutional managers holding positions valued at $23.3M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

20.7%

Institutional managers

Reported 13F value

$23.3M

Insider activity

38 trans.

−$277.4K net selling

Data flags

2 active

from SEC filings

Latest updates

2026-07-02 — Insider transaction reported (Form 4)
2026-07-01 — Notice of proposed sale filed (Form 144)
2026-06-22 — Current report (8-K) filed
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)
2026-06-18 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, GENELUX CORPORATION has 70 institutional holders and institutional ownership of 20.7%.

Insider activity

Insiders reported 38 transactions (0 buys, 23 sells) across 9 reporting insiders, with a net reported value of −$277.4K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2023-03-29) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-07-14 (recurring since 2023-07-14) — source filing. The authoritative details are those stated in the filing itself.

Related companies

LIPOCINE INC NEW (LPCN) · TELIX PHARMACEUTICAL LTD (TLX) · GYRE THERAPEUTICS INC (GYRE) · INOTIV INC (NOTVQ) · FILANA THERAPEUTICS INC (FLNA) · NEXTCURE INC (NXTC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.